REXEL ● The stock, which is currently worth 2020 to 0.46 times its sales, is clearly overvalued in comparison with peers.
Weaknesses
● Stock prices approach a strong long-term resistance in weekly data at EUR 13.27.
● The stock is close to a major daily resistance at EUR 12.09, which should be gotten rid of so as to gain new appreciation potential.
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The company has insufficient levels of profitability.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● Analysts covering the stock have recently lowered their earnings forecast.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● For the past year, analysts have significantly revised downwards their profit estimates.
